Exponent Inc
24/7 Wall St. View
EXPO at a Glance
- Market cap
- $3.7B
- P/E ratio
- 34.7
- Dividend yield
- 1.58%
- Revenue (TTM)
- $567.1M
- Profit margin
- 19.7%
- EPS (TTM)
- $2.26
- 52-week range
- $51 – $83
- 24/7 target
- $97.91
- Street target
- $84.00
Headquartered in Menlo Park, CA Fiscal year ends December NASDAQ: EXPO exponent.com
About Exponent
Exponent, Inc. (Nasdaq: EXPO) is a science and engineering consulting firm. It brings together more than 90 technical disciplines and over 950 consultants to help clients across more than a dozen industries with complex technical, safety, health and environmental challenges. Its roots are in failure analysis, and it operates two reporting segments. Engineering and Other Scientific accounted for about 85% of revenues before reimbursements in Q3 2026. It covers user research studies on human interaction with technology, dispute-related and failure analysis work in industries such as chemicals, consumer products and advanced transportation, validation of AI-enabled systems, and critical infrastructure work. Environmental and Health accounted for about 15% and assesses the effects of chemicals on human health and the environment. Exponent's clients include multinational companies, startups, law firms, insurance companies and governments. It serves both reactive engagements, such as incident response and litigation support, and proactive engagements, such as product development, regulatory and design support. Work is delivered through consultants, laboratories, databases and computing resources across offices in North America, Asia and Europe. The company returns capital through quarterly dividends and share repurchases. Updated
Frequently Asked Questions
What does Exponent do?
Exponent, Inc. (Nasdaq: EXPO) is a science and engineering consulting firm. It brings together more than 90 technical disciplines and over 950 consultants to help clients across more than a dozen industries with complex technical, safety, health and environmental challenges.
What is the EXPO stock price target?
24/7 Wall St.'s 12-month price target for EXPO is $97.91, rated Buy. The Wall Street consensus target is $84.00. EXPO price prediction →